7Baggers
 CVKD: Acquires Factor XIa Inhibitors  Smartkarma Wed, 01 Oct 2025 02:48:34 GMT
 cvkd: acquires factor xia inhibitors…  Yahoo Finance Tue, 30 Sep 2025 11:05:00 GMT
 Cadrenal therapeutics (CVKD) CEO Pham sells $131,779 in stock By Investing.com  Investing.com South Africa Sat, 27 Sep 2025 16:07:45 GMT
 Szot, CFO of Cadrenal, sells $174k in CVKD stock By Investing.com  Investing.com South Africa Sat, 27 Sep 2025 02:19:56 GMT
 Szot, CFO of Cadrenal, sells $174k in CVKD stock  Investing.com Sat, 27 Sep 2025 00:49:52 GMT
 Cadrenal Therapeutics Elects New Director at Meeting  TipRanks Thu, 25 Sep 2025 08:39:46 GMT
 Deal Watch: Biogen Acquires Intrathecal Delivery Specialist Alcyone  insights.citeline.com Fri, 19 Sep 2025 07:00:00 GMT
 cadrenal therapeutics, inc. (cvkd) gets a buy from noble financial  The Globe and Mail Wed, 17 Sep 2025 14:06:00 GMT
 Pharmaceutical Technology  Pharmaceutical Technology Wed, 17 Sep 2025 08:19:18 GMT
 Cadrenal Therapeutics acquires eXIthera’s Factor XIa inhibitors  Yahoo Finance Tue, 16 Sep 2025 07:00:00 GMT
 cadrenal therapeutics acquires exithera’s assets for growth  TipRanks Tue, 16 Sep 2025 06:54:23 GMT
 why is atyr stock falling today?  Stocktwits Mon, 15 Sep 2025 13:31:57 GMT
 Cadrenal Therapeutics acquires eXIthera Pharmaceuticals  Jacksonville Daily Record Mon, 15 Sep 2025 07:00:00 GMT
 Cadrenal Therapeutics Acquires eXIthera’s Assets for Growth  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 Cadrenal Therapeutics acquires eXIthera’s anticoagulant portfolio  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 published on: 2025-09-15 01:20:40  newser.com Mon, 15 Sep 2025 06:20:40 GMT
 published on: 2025-09-14 16:19:54  newser.com Sun, 14 Sep 2025 21:19:54 GMT
 published on: 2025-09-14 13:19:36  newser.com Sun, 14 Sep 2025 18:19:36 GMT
 published on: 2025-09-14 12:17:38  newser.com Sun, 14 Sep 2025 17:17:38 GMT
 published on: 2025-09-13 04:58:26  newser.com Sat, 13 Sep 2025 09:58:26 GMT
 published on: 2025-09-12 00:33:27  Newser Fri, 12 Sep 2025 05:33:27 GMT
 how us health policy affects entrepreneurship  Bloomberg.com Fri, 05 Sep 2025 18:31:37 GMT
 Watch How US Health Policy Affects Entrepreneurship  Bloomberg.com Fri, 05 Sep 2025 07:00:00 GMT

Cadrenal Therapeutics
(NASDAQ:CVKD) 

CVKD stock logo

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fib...

Founded: 2022
IPO Price: $5 (Jan 20, 2023)
Full Time Employees: 1
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends